Miller Straight Blade vs Macintosh Blade
Launched by TATA MAIN HOSPITAL · Jan 22, 2016
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
One hundred and fifty patients with predicted non difficult airway were randomly assigned into two groups. After induction of anaesthesia laryngoscopy was performed with respective blades and trachea intubated. Parameters monitored were: glottis view obtained during laryngoscopy (Cormack Lehane grade), ease of intubation, intubation attempts, total duration of laryngoscopy in seconds and encountered complications.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All ASA I \& II grade patients undergoing elective surgery requiring general anesthesia with oral endotracheal intubation
- Exclusion Criteria:
- • Patients with anticipated difficult airway
- • Cervical spine disorders
- • Anesthesia requiring rapid sequence induction
About Tata Main Hospital
Tata Main Hospital (TMH) is a leading healthcare institution in India, renowned for its commitment to excellence in patient care, research, and education. As a prominent sponsor of clinical trials, TMH fosters innovative medical research aimed at advancing treatment options and improving health outcomes. With a multidisciplinary team of experienced healthcare professionals and state-of-the-art facilities, TMH is dedicated to conducting rigorous clinical studies that adhere to the highest ethical standards and regulatory requirements. The hospital's collaborative approach and focus on patient-centric research contribute to the development of safe and effective therapies, enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Bhanu Pratap Swain, DNB
Principal Investigator
Tata Main Hospital, Jamshedpur,India
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials